Skip to content

Faster TB Test for Resource-Limited Settings

  • Chad Cipiti

By Theo Smart First published February 2, 2007 on AIDSmap.com. A large multicenter study conducted in Honduras and Brazil has shown that a new and relatively simple technique to detect active tuberculosis (TB), the microscopic observation drug susceptibility (MODS) test,…

Read more

Basic Research Is a Government Responsibility

  • Chad Cipiti

By Robert Siliciano, MD, PhD Excerpts from testimony before the U.S. Senate Committee on Appropriations, March 19, 2007. The United States has long been the world leader in scientific discovery, thanks largely to government policies that encourage innovation, improve education,…

Read more

Immune Activation in HIV Infection: More Than Just Markers

  • Chad Cipiti

More Than Just Markers By Richard Jefferys "... no longer solely of interest to academic immunologists ..." At the recent International AIDS Society conference in Sydney, Mike Lederman reminded attendees that abnormally high levels of immune activation were described in the first…

Read more

Tuberculosis Research & Development: A Critical Analysis

  • Chad Cipiti

TAG interviewed 100 institutions and documented the top 40 investors in TB R&D in 2005. Results highlighted in the report showed that new tools including diagnostics, drugs and vaccines received combined funding of $206 million in 2005 -- diagnostics, $16…

Read more

How We Treat TB Today: A Talk With Gavin Churchyard

  • Chad Cipiti

A Talk With Gavin Churchyard By Mark Harrington Professor Gavin Churchyard is the director of the Aurum Institute for Health Research, which provides health care services to many mining companies in South Africa but is also an independent health research…

Read more

TB Transmission in Healthcare Settings

  • Chad Cipiti

By Theo Smart In all the news and hype about the cases of extensively drug resistant tuberculosis (XDR-TB) in KwaZulu Natal, South Africa, there has been surprisingly little discussion about how and where many of the people acquired the XDR-TB…

Read more

Gut Reactions

  • Chad Cipiti

By Richard Jefferys The biggest obstacle to understanding how HIV causes immune damage is the complexity of the human immune system, a vast collection of different cells and tissues that typically work together in concert to protect against disease. HIV…

Read more

Update: Leaking LPS

  • Chad Cipiti

As this issue went to press, a paper appeared from Daniel Douek and colleagues reporting data which, the authors argue, further supports the model of HIV pathogenesis outlined in their Nature Immunology review. Douek's group had previously speculated that one…

Read more

In Brief

  • Chad Cipiti

Stavudine Associated With Risk for Type-2 Diabetes Generic Efavirenz/Tenofovir/FTC Combo Compulsory License for Efavirenz in Thailand Why Do People Still Die After Taking ARVs? Is it the Brand of Drugs? Stavudine Associated With Risk for Type-2 Diabetes By Simon Collins,…

Read more
Back To Top